Effect of dasatinib on the BCR-ABL signaling pathway. Phosphorylation... | Download Scientific Diagram
The most sensitive (IC50 < 1 nmol/L) cytosolic and membrane targets of... | Download Scientific Diagram
Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors - ScienceDirect
IJMS | Free Full-Text | Philadelphia Chromosome-Positive Leukemia in the Lymphoid Lineage—Similarities and Differences with the Myeloid Lineage and Specific Vulnerabilities | HTML
Bcr-Abl tyrosine-kinase inhibitor - Wikipedia
Dasatinib - Tyrosine Kinase Inhibitor for Chronic Myeloid Leukaemia (CML) - Clinical Trials Arena
Dasatinib inhibits TGFβ-induced myofibroblast differentiation through Src-SRF Pathway. - Abstract - Europe PMC
Src inhibition of Dasatinib decreases cellular proliferation, survival,... | Download Scientific Diagram
CML therapy : post-Gleevec® era - ppt download
Sprycel 70mg Tablets - Rosheta
Targeting the kinome: bosutinib versus dasatinib. Emphasizing the... | Download Scientific Diagram
Mechanism of Action | Multikinase Inhibitors
The Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain Elucidates Its Inhibitory Activity against Imatinib-Resistant ABL Mutants | Cancer Research
TYROSINE KINASE INHIBITORS
Dasatinib-70 - Healeasy Services
Dasatinib (Sprycel) - Oncology Nurse Advisor
A schematic model for the anti-cancer function of Dasatinib and... | Download Scientific Diagram
Dasatinib and Torin 1 block translation of CHIKV sgmRNA. In this study,... | Download Scientific Diagram
Pharmacology - CANCER DRUGS – CELL CYCLE SPECIFIC AND NONSPECIFIC AGENTS (MADE EASY) - YouTube
Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events | Arteriosclerosis, Thrombosis, and Vascular Biology
BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis? - Abstract - Europe PMC
Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors | Clinical Cancer Research
Dasatinib - Tyrosine Kinase Inhibitor for Chronic Myeloid Leukaemia (CML) - Clinical Trials Arena
